- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Articles on Momenta Pharmaceuticals Inc. (MNTA)
by latest | most commented
-
Big Movers in Healthcare - JAZZ, HEB, MNTA, MBLX and OCLS
-
30 Possible Pandemic Profit Plays: Bullish Biotech and Drug Stocks to Watch
-
16 'Bathwater Babies' and 20 'Dogs with Fleas' for the Week
-
Three Oversold Healthcare Catalyst Stocks
-
Momenta Pharma Pursuing a Three-Part Strategy
-
Biotech Going Generic Like Big Pharma?
-
Trading FDA Decisions: Cypress Bioscience Soars, A Trio of Buys
-
20 Emerging Healthcare Stocks to Watch in '09
-
Nine for '09 Picks Start Strong
-
Momenta Pharma's Opportunities Abound
-
Small, Defensive 2009 Stock Picks Are Soaring
-
Nine for '09: Staying Defensive in the New Year
-
Investment Ideas That Stand Out from ETF Innovators New Indexes
-
Stocks Offering 'Healthy' Returns
-
Teva Beats On Profits
-
Four Biotechs at Attractive Entry Points
-
Generic Drug Industry Outperforms Drug and Healthcare ETFs
-
Overview and Analysis of the Global Generic Drug Industry
-
Momenta Pharma Investors In Waiting Game on Enoxaparin
-
Pharmaceuticals: Near Term Movers Based On FDA Decision Dates
-
Momenta Pharma: A Waiting Game
-
FDA Calendar: Cardiome, Momenta, Discovery Labs, Introgen
-
Best and Worst Performing Stocks Seven Months Into 2008
-
Another Month of '08 in the Books
-
Wednesday's Options Report: C, V, BCO, VLO, CBI, MNTA, CLX
-
Momenta Pharma: Expect Upside Following Game-Changing Upgrade
-
Q1's Best and Worst Performing Stocks
-
The Next Great Biotech Short Squeeze
-
Is Momenta's Stock Plunge Justified?
-
Biotech Day In Review: Sanofi Loses Lovenox Patent